Consilium Wealth Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Consilium Wealth Advisory's LLY Position: Q2 2026 in Review
Consilium Wealth Advisory reduced its Eli Lilly (LLY) stake by 0.24% in Q2 2026, selling an estimated $9.2K and leaving 3,713 shares worth $4.45M. The position accounts for 1.32% of the portfolio, ranked #19.
Consilium Wealth Advisory first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Consilium Wealth Advisory held 3,713 shares of Eli Lilly worth $4.45M as of Q2 2026.
- Consilium Wealth Advisory sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
- Eli Lilly made up 1.32% of Consilium Wealth Advisory's portfolio in Q2 2026, its #19 holding.
- Consilium Wealth Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Consilium Wealth Advisory's 13F filing for Q2 2026, filed 11 Aug 2026.